SECR reporting for healthcare — UK compliance guide

If you operate a UK private hospital group, healthcare services business, dental group, care home group, diagnostics provider, life sciences company or medical devices manufacturer meeting the SECR thresholds (£36M+ turnover, £18M+ balance sheet, or 250+ employees), this guide covers what to file and where most healthcare businesses get it wrong.

SECR challenges specific to healthcare

Four problems generic SECR templates don't handle for healthcare:

1. Anaesthetic gas emissions. Desflurane, sevoflurane, isoflurane and nitrous oxide are clinical gases with very high global warming potentials (desflurane GWP100 = 2,540; nitrous oxide GWP100 = 273). Annual use of even small kg quantities produces material scope 1 emissions. The Royal College of Anaesthetists and Greener NHS have published clinical and reporting guidance.
2. Medical gas refrigeration and F-gas leakage. Diagnostic equipment (MRI, CT) and pharmacy refrigeration use refrigerants with high GWPs; leak rates from older estate equipment can be high. Hospital catering refrigeration adds to the load.
3. Clinical waste streams have distinctive emissions factors. Clinical waste, anatomical waste, pharmaceutical waste and sharps each have different treatment routes (high-temperature incineration with energy recovery, autoclave-then-landfill, deep landfill). DEFRA factors differ from municipal waste.
4. NHS Net Zero alignment is the reference standard, even for private providers. The NHS Net Zero Supplier Roadmap requires NHS suppliers (which most private healthcare and life sciences firms are) to publish carbon reduction plans aligned to NHS targets. SECR is the foundation for that disclosure.

Typical scope 1 emissions in healthcare

Scope 1 for healthcare typically includes:

• Natural gas — building heating, hot water, sterilisation, catering
• Diesel — back-up generators (critical for hospitals — a resilience requirement)
• Diesel and petrol — owned vehicle fleet (community nursing, mobile diagnostics, private ambulance fleet)
• F-gas refrigerant leakage — diagnostic imaging (MRI helium boil-off, CT cooling), pharmacy refrigeration, catering refrigeration, building HVAC
• Anaesthetic gases — desflurane, sevoflurane, isoflurane, nitrous oxide (operating theatres, dental sedation, day surgery)
• Medical gases — small clinical loss / venting from oxygen and Entonox systems
• LPG and propane — off-mains heating for some rural facilities

Anaesthetic gases are the most distinctive scope 1 source. A medium-sized hospital running 20+ theatres can emit 500–2,000+ tCO₂e/year from desflurane alone if not actively managed. Switching from desflurane to sevoflurane (lower GWP) is one of the highest-impact clinical decarbonisation interventions.

Typical scope 2 emissions in healthcare

Scope 2 is grid electricity:

• Lighting and small power — ward, theatre, diagnostic and office areas
• HVAC and clinical air handling — operating theatres require very high air-change rates; significant electrical load
• Diagnostic imaging power — MRI, CT, ultrasound
• Sterilisation equipment (autoclaves, washer-disinfectors)
• Pharmacy refrigeration
• Hot water systems (where electric)
• Catering and laundry (where on-site)
• IT systems and EHR / PACS infrastructure

Hospitals are 24/7 operations with high specific energy consumption — typically 350–700 kWh/m²/year, much higher than office or retail benchmarks. DEC (Display Energy Certificate) data, where available, provides a useful benchmark.

Scope 3 considerations for healthcare

Scope 3 is voluntary for SECR, but for healthcare it dominates — clinical procurement (drugs, devices, consumables, PPE) typically accounts for 60–75% of total healthcare emissions. Critical categories:

• Category 1 — Purchased goods and services — pharmaceuticals (often 20–30% of total emissions alone), medical devices, single-use consumables, PPE, catering supply, IT services
• Category 2 — Capital goods — diagnostic equipment, theatre fit-outs, IT hardware
• Category 4 — Upstream transportation — pharma and consumables logistics
• Category 5 — Waste from operations — clinical waste, sharps, pharmaceutical waste, anatomical waste, municipal waste
• Category 6 — Business travel
• Category 7 — Employee commuting — significant; many clinical sites have 1,000+ staff
• Category 11 — Use of sold products — for life sciences / medical device manufacturers, the in-use emissions of devices sold
• Patient travel — sometimes considered scope 3 category 9; NHS Net Zero includes it, most private providers exclude it from SECR year 1

For NHS suppliers, the NHS Carbon Reduction Plan Supplier Engagement template defines the disclosure expectations — align SECR scope 3 to that framework.

Common mistakes healthcare businesses make

1. Missing anaesthetic gas emissions — pharmacy and theatre logs aren't routinely visible to sustainability or finance teams
2. Underestimating F-gas leakage from MRI, CT and pharmacy refrigeration — service contractor reports needed
3. Using municipal waste factors for clinical waste — DEFRA factors differ materially
4. Excluding pharmaceuticals from scope 3 because data is hard — for healthcare, this is the dominant emissions source; year 1 spend-based is acceptable
5. Forgetting patient transport (Patient Transport Service, private ambulance) — scope 1 if owned, scope 3 if contracted
6. Reporting tCO₂e per £1M turnover without per bed-day or per patient-episode (the sector intensity metric)
7. Not aligning to the NHS Net Zero Supplier Roadmap — if you supply the NHS, alignment is now a tender requirement
8. Treating tenanted GP / dental practices as in scope when they're separate legal entities

Trade body context — Greener NHS, IHPN, Care England

The Greener NHS programme publishes the NHS Net Zero strategy, the Carbon Footprint Plus methodology and the Net Zero Supplier Roadmap. For private healthcare, alignment to this framework is now the standard reference.

The Independent Healthcare Providers Network (IHPN) represents UK private healthcare and has published sector sustainability guidance. For life sciences and pharma, the ABPI (Association of the British Pharmaceutical Industry) has published guidance, and the SBTi pharma sector decarbonisation pathway is the science-based reference.